MedPath

Protein-rich Nutritional Therapy Combined With Time-efficient Exercise in Cancer Therapy

Not Applicable
Conditions
Cancer Cachexia
Inflammation
Cancer
Interventions
Other: Resistance Training
Other: High-intensity interval training (HIIT)
Other: WB-EMS
Other: Combined HIIT and Resistance Training (Combi)
Registration Number
NCT04065815
Lead Sponsor
University of Erlangen-Nürnberg Medical School
Brief Summary

This study aims to evaluate the effects of a 12-week protein-rich individualized nutritional therapy combined with different time-efficient exercise programs on overall physical fitness (cardiorespiratory fitness and muscular fitness), inflammation, and muscle mass/body composition in patients with malignant disease undergoing curative or palliative anti-cancer treatment

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • malignant disease (solid or hematological cancer): head and neck cancer, colorectal carcinoma, small intestinal cancer, gastric cancer, oesophageal cancer, pancreas carcinoma, liver cell carcinoma, cholangiocarcinoma, lung cancer, breast cancer, cervix cancer, ovarian cancer, prostate cancer, renal cell carcinoma, malignant melanoma, patients with leukaemia and malignant lymphomas or Graft-versus-Host-Disease after bone marrow transplantation
  • ongoing or planned curative or palliative anti-cancer therapy
  • ECOG-Status 0-2
Exclusion Criteria
  • simultaneous participation in other nutritional or exercise intervention Trials
  • bone metastases with high fracture risk
  • cardiovascular disease
  • use of anabolic medications
  • epilepsy
  • severe neurological or rheumatic diseases
  • skin lesions in the area of electrodes
  • energy active metals in body
  • pregnancy
  • acute vein thrombosis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Resistance Training (RT)Resistance TrainingIndividualized, protein-rich nutritional therapy combined with resistance training
High-intensity interval training (HIIT)High-intensity interval training (HIIT)Individualized, protein-rich nutritional therapy combined with high-intensity interval training (HIIT)
WB-EMSWB-EMSIndividualized, protein-rich nutritional therapy combined with whole-body electromyostimulation (WB-EMS)
Combined HIIT and Resistance Training (Combi)Combined HIIT and Resistance Training (Combi)Individualized, protein-rich nutritional therapy combined with a combined high-intensity interval training (HIIT) and resistance training
Primary Outcome Measures
NameTimeMethod
Overall physical fitness12 weeks

Cardiorespiratory Fitness and Muscular Fitness (Overall Fitness Score is calculated from Maximum Oxygen uptake, VO2max, and Muscle strength (estimated from the 1-repetition Maximum - the maximum amount of weight \[kg\] that can be lifted for one repetition) of the five major muscle groups (chest, upper back, lower back, abdominals, legs)

Secondary Outcome Measures
NameTimeMethod
Patient-reported performance status-112 weeks

Patient-reported performance Status will be assessed using the ECOG Performance Status questionnaire. It describes a patient's level of functioning in terms of their ability to care for themself, daily activity, and physical ability. The score ranges from 0-5 (lower values = better outcome).

Patient-reported Physical Activity12 weeks

Patient-reported Physical Activity (PA) will be assessed using the the International Physical Activity Questionnaire (IPAQ). IPAQ records 4 aspects of PA (job-, transportation-, housework-, and leisure-time-related). There are two forms of output from scoring the IPAQ. Results can be reported in categories (low, moderate or high PA levels) or as a continuous variable (MET minutes a week, 1 MET = resting energy expenditure). MET minutes represent the amount of energy expended carrying out physical activity. High PA = at least 1500 MET minutes/week; moderate PA: at least 600 MET minutes/week; low PA: \< 600 MET minutes/week. Higher values represent a better outcome.

Cardiometabolic Risk Profile (Metabolic Syndrome Z-Score, MetS)12 weeks

MetS will be calculated MetS-Z-Score will be calculated from each individual's measures of waist circumference (cm), mean arterial blood pressure (mmHg), blood levels of glucose (mg/dL), triglycerides (mg/dL), and HDL-cholesterol (mg/ dL), based on equations specific to sex.

Fat mass12 weeks

Fat mass (kg) is assessed by bioelectrical impedance Analysis (BIA)

Total Body Water12 weeks

Total Body Water (L) is assessed by bioelectrical impedance Analysis (BIA)

Patient-reported performance status-212 weeks

Patient-reported performance status-2 will be assessed using the Karnofsky index. It is used methods to assess the functional status of a Patient. The score ranges from 0-100 (higher value = better outcome).

Objective Physical Activity12 weeks

Objective measurement of physical activity will be preformed using Pedometers. Higher values represent a better outcome.

Inflammatory blood markers12 weeks

Inflammation will be assessed by measuring blood levels (mg/L) of c-reactive protein (CRP) and high-sensitivity creactive protein (hs-CRP).

Muscle mass12 weeks

Muscle mass (kg) is assessed by bioelectrical impedance Analysis (BIA)

Patient-reported Quality of Life (QoL)12 weeks

Patient-reported QoL will be assessed using the EORTC QLQ-C30 questionnaire. It contains 30 questions (items), representing various aspects/dimensions of QoL (physical, role, emotional, cognitive and social), and 3 symptom scales (fatigue, pain and nausea).The scales of the different dimensions of QoL (higher values = better outcome) and symptoms (lower values = better outcomes) range from 0-100.

Patient-reported Fatigue12 weeks

Fatigue will be assessed using the FACIT-Fatigue scale. It contains 13 items (different aspects/dimensions of fatigue) each assessed on a scale of 0-4, with lower values indicating a better outcome).

Trial Locations

Locations (1)

Department of Medicine 1, Hector-Center for Nutrition, Exercise and Sports

🇩🇪

Erlangen, Germany

© Copyright 2025. All Rights Reserved by MedPath